SEC Form 4 · accession 0001638599-16-001445
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Una S Ryan
Director
Period of report
Oct 5, 2016
Accepted (ET)
Oct 6, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 5, 2016 | M | 5,000 | $11.83 | A | 46,541 | D | |
| Common Stock | Oct 5, 2016 | F | 3,498 | $16.91 | D | 43,043 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF2 | $11.83 | Oct 5, 2016 | M | 5,000 | D | — | Oct 30, 2016 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1Consists of shares withheld to pay exercise price.
- F2This option is currently exercisable.